CBD, or cannabidiol, is quickly becoming one of the most well-known compounds found within the cannabis plant. Unlike it’s even more popular counterpart THC (tetrahydrocannabinol), CBD does not give consumers the “high” that recreational cannabis gives. CBD instead is a non-psychoactive anti-inflammatory compound that is increasingly being used as a mainstream medicinal substance.
WHAT IS CBD?
CBD is one of the many present cannabinoid compounds found within the plant. It is found at lower levels than THC is in most recreationally grown cannabis, though recently, high CBD strains like Charlotte’s Web are seeing more popular demand. A strain like Charlotte’s Web, which was developed specifically for a child who was suffering from epilepsy, is perfect for those who believe in and enjoy the medicinal benefits of cannabis but do not want to experience any psychoactive effects. Though these strains are much harder to genetically engineer and grow, they are becoming much more popular as more information about the benefits of CBD becomes public knowledge.
USES OF CBD
The cannabis plant has been used for centuries as a medicine but only recently has research about CBD become mainstream. There are many scientifically studied benefits of CBD. Generally, CBD has an anti-inflammatory profile that makes it good for healing and recovery.
More specifically, studies have found CBD as an effective treatment for such afflictions as epilepsy, Crohn’s disease, and even anxiety. Dr. Robert Carson, an assistant professor of neurology and pediatrics at Vanderbilt University, has stated, “In children, especially those with autism spectrum disorders, this may manifest as improved interactions with others.”
CONSUMER CAUTION IS WARRANTED
Though CBD has been proven to be effective in treating certain diseases, users of the compound must be weary of what they are using and where they are getting it. A report released Thursday, May 24th, 2018 by the Centers for Disease Control and Prevention found that products falsely labeled as CBD, sickened as many as 52 people from October through January. According to the CDC report, “more than half of the 52 possible cases either tested positive for a synthetic compound called 4-CCB or reporting using a product called Yolo CBD Oil, samples of which contained the synthetic instead of authentic CBD.”
The mislabeling, whether intentional or not, of cannabis products is directly linked to the government’s timidity regarding cannabis legalization. The inability to regulate a product deemed federally illegal allows for cannabis product manufacturers to avoid a strict testing process that would weed out any mislabeled or dangerous products.
CANNABIS COMPOUND CBD HAS A BRIGHT FUTURE
CBD has only very recently gained mainstream acceptance. Due to decades of relative obscurity, there are far fewer CBD products and strains then there are high-THC products on the market. Hopefully through legalization and eventually stringent regulatory processes, more people will be exposed to the non-psychoactive health benefits of CBD.